Practising Law Institute (PLI) will be offering a audio-only webcast entitled: "Pharmaceutical and Biotech Patent Law: Recent Developments" on December 13, 2007 from 1:00-2:00 PM (EST).  The presentation is part of PLI's One-Hour Patent Hot Topic Briefing series.  Speakers David K. Barr and Daniel L. Reisner of Kaye Scholer LLP, co-editors of the PLI treatise "Pharmaceutical and Biotech Patent Law," will provide an overview of the patent law issues that arise in the drug approval process, from research and development through FDA approval, and will then discuss recent case law decisions that particularly affect the pharmaceutical and biotech industries.  In addition, the speakers will cover the following topics and issues:

• The drug development process and the types of patents that result from that process.
• The patent issues that arise during the various phases of the development of a drug product, including early-stage research in drug discovery, preclinical development, clinical trials, and the FDA approval process.
• Recent case law developments, including:
  • KSR v. Teleflex — the Supreme Court's reevaluation of the law of obviousness,
  • Takeda v. Alapharm — the Federal Circuits first pharmaceutical case following KSR,
  • Significant decisions governing the patentability of active pharmaceutical ingredients, including: Sanofi-aventis v. Apotex, Pfizer v. Apotex, and Aventis v. Lupin,
  • In re Seagate Technology — which redefined the standard for establishing willful infringement in patent infringement cases

The registration fee for this webcast is $299, and registrants will be entitled to a 40% discount off the price of the PLI treatise "Pharmaceutical and Biotech Patent Law."  Those interested in registering for the webcast, can do so here.